MetabolismNews.net

Metabolism Xagena

Search results for "Hypocalcemia"

The U.S. FDA ( Food and Drug Administration ) approved once- monthly oral Ibandronate ( Boniva ) 150 mg tablets, the first and only once-a-month drug for the treatment of postmenopausal osteoporosis. ...


Prolia ( Denosumab ) is designed to inhibit RANKL ( RANK ligand ), a protein that acts as the primary signal for bone removal. Activation of RANK by RANKL promotes the maturation of pre-osteoclasts in ...


La Food and Drug Administration ( FDA ) has approved a new indication for Prolia ( Denosumab ) as a treatment to increase bone mass in men with osteoporosis at high risk for fracture. Prolia, the firs ...


The risks of developing kidney failure and a calcium deficiency from osteoporosis drug Zoledronic acid ( Aclasta; Reclast ) are extremely rare, according to researchers at Loyola University Health Sys ...